Kyverna Therapeutics, Inc.
KYTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001994702
No open-market purchases or sales by Kyverna Therapeutics, Inc. insiders were filed in the last 90 days; 120 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Kyverna Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 111
- +13 vs. Q4 2025
- Shares held
- 34.8M
- +2.47M (+7.6%) vs. Q4 2025
- Total value
- $300.5M
- −$3.51M (−1.2%) vs. Q4 2025
- New holders
- 27
- 31 more added
- Sold out
- 14
- 35 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 120 | $335.1M |
| Q1 2026 | 111 | $300.5M |
| Q4 2025 | 99 | $320.8M |
| Q3 2025 | 75 | $136.1M |
| Q2 2025 | 79 | $71.2M |
| Q1 2025 | 87 | $49.8M |
| Q4 2024 | 88 | $108.0M |
| Q3 2024 | 94 | $138.3M |
| Q2 2024 | 88 | $239.7M |
| Q1 2024 | 90 | $762.3M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Kyverna Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 977,289 | $8.43M | 0.00% | −25,206−2.5% | Reduced |
| Insight Holdings Group, LLC | 989,054 | $8.54M | 0.60% | 00.0% | Unchanged |
| Millennium Management LLC | 1,005,508 | $8.68M | 0.01% | +412,139+69.5% | Added |
| Balyasny Asset Management LLC | 1,125,321 | $9.71M | 0.02% | +144,452+14.7% | Added |
| Price T Rowe Associates Inc | 1,555,287 | $13.4M | 0.00% | −207,330−11.8% | Reduced |
| Vanguard Capital Management LLC | 1,783,342 | $15.4M | 0.00% | +1,783,342 | New |
| Deerfield Management Company, L.P. (Series C) | 2,000,000 | $17.3M | 0.20% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 2,000,000 | $17.3M | 3.53% | +500,000+33.3% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,110,000 | $26.8M | 2.42% | 00.0% | Unchanged |
| Gilead Sciences, Inc. | 4,126,119 | $35.6M | 1.68% | 00.0% | Unchanged |
| GordonMD Global Investments LP | 4,244,818 | $36.6M | 30.18% | −147,000−3.3% | Reduced |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| RFG Advisory, LLC | 0 | $0 | 0.00% | −445,200−100.0% | Sold out |
| Heights Capital Management, Inc | 0 | $0 | 0.00% | −271,822−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −195,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −146,400−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −49,400−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,282−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Cambria Investment Management, L.P. | 0 | $0 | 0.00% | −17,935−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −16,343−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −10,048−100.0% | Sold out |
| Vermillion & White Wealth Management Group, LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |